COVID-19 vaccination cuts infection risk by half in school-aged children - REACT
ICTU Global Launch
GMRx2 Placebo Controlled Trial (PCT)
First Site Initiated for GMRx2 ACT
UNEEG Medical Hyposafe System – An Exploratory Feasibility Study
TOPSPIN trial presented at AHA 2024
Imperial ranks second in the world in major university ranking
ZODIAC trial presented at AHA
